refractory, advanced Sezary Syndrome

DBCOND0089470LymphomasRetroviridae Infections

refractory, advanced Sezary Syndrome is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
refractory, advanced sezany syndrome · Sezary syndrome refractory · refractory Sezary Syndrome
Classified under
Indicated drugs

Resolves to

Vocabularies
MedDRA10011679UMLSC0862204

What you can answer from here — as of October 31, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for refractory, advanced Sezary Syndrome share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In